Skip to main content
Advanced Cancer Therapies Main banner
Icon Legend

  1. Home

  • Saturday, Feb 17th
    7:30 AM - 8:30 AM AST
    HPB Abstract Session
    Location: Miramar I & II
    Moderator: Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
    Moderator: Kelly J. Lafaro, MD, MPH (she/her/hers) – Division of Hepatobiliary and Pancreas Surgery, Department of Surgery, Johns Hopkins Hospital
    HPBCME
  • Saturday, Feb 17th
    7:30 AM - 7:40 AM AST
    25: Navigating Complications and Functional Lifespan: A Single-Center's Review of Hepatic Artery Infusion Pumps
    Location: Miramar I & II
    Abstract Presenter: Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus
    Submitter: Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus
    Author: Salvador Rodriguez Franco, MD (he/him/his) – University of Colorado Anschutz Medical Campus
    Author: Sumaya Abdul Ghaffar, MD – University of Colorado
    Author: Mona Hamermesh, PA – University of Colorado Anschutz Medical Campus
    Author: Reed Weiss, RN, NP – University of Colorado Anschutz Medical Campus
    Author: Andrii Khomiak, MD – University of Colorado Anschutz Medical Campus
    Author: Madeline B. Thomas, MD (she/her/hers) – University of Colorado Anschutz Medical Campus
    Author: Benedetto Mungo, MD – University of Colorado, Department of Surgery
    Author: Marco Del Chiaro, MD, PhD – University of Colorado Anschutz Medical Campus
    Author: Richard D. Schulick, MD, MBA – University of Colorado, Department of Surgery
    Author: Ana L. Gleisner, MD, PhD – University of Colorado
    HPB
  • Saturday, Feb 17th
    7:40 AM - 7:50 AM AST
    26: A Prospective Evaluation of a Modified Hepatic Arterial Infusion Floxuridine Reduced-Dose Protocol for Patients with Unresectable Colorectal Liver Metastases
    Location: Miramar I & II
    Abstract Presenter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Submitter: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Issac R. Schwantes, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Ranish K. Patel, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Adel Kardosh, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Jillian Paxton, PharmD – OHSU, Department of Pharmacy Services, Portland, OR 97239 USA
    Author: Robert Eil, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Emerson Chen, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Flavio G. Rocha, MD – Oregon Health & Science University (OHSU), Department of Surgery, Division of Surgical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Emile J. Latour, MS – Biostatistics Shared Resource, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Guillaume Pegna, MD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Charles Lopez, MD PhD – Department of Medicine, Division of Hematology and Medical Oncology, Knight Cancer Institute, Portland, OR 97239 USA
    Author: Skye C. Mayo, MD MPH (he/him/his) – Department of Surgery, Division of Surgical Oncology, Oregon Health & Science University; Knight Cancer Institute; Portland, OR 97239 USA
    HPB
  • Saturday, Feb 17th
    7:50 AM - 8:00 AM AST
    27: Initial Outcomes of a Single-Institution Hepatic Artery Infusion Pump Program for Colorectal Liver Metastases and Intrahepatic Cholangiocarcinoma
    Location: Miramar I & II
    Abstract Presenter: Henry J. Stitzel, BS – Case Western Reserve University School of Medicine
    Submitter: Henry J. Stitzel, BS – Case Western Reserve University School of Medicine
    Author: Henry J. Stitzel, BS – Case Western Reserve University School of Medicine
    Author: Michelle Chung, MD – University Hospitals
    Author: Sree Harsha Tirumani, MD – Department of Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: David Bajor, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Sakti Chakrabarti, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Melissa Lumish, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Madison Conces, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Amit Mahipal, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Lauren Henke, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: John B. Ammori, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Jeffrey M. Hardacre, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Jordan M. Winter, MD, MBA – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Jennifer Selfridge, MD, PhD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Lee M. Ocuin, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    HPB
  • Saturday, Feb 17th
    8:00 AM - 8:10 AM AST
    28: Perioperative and oncologic outcomes of hepatic arterial infusion pump chemotherapy for patients with unresectable colorectal liver metastases at an expanding HAI program
    Location: Miramar I & II
    Abstract Presenter: Annie Liu, MD PhD – Duke University Medical Center
    Submitter: Annie Liu, MD PhD – Duke University Medical Center
    Author: Annie Liu, MD PhD – Duke University Medical Center
    Author: Melissa Lowe, MS – Duke Cancer Institute
    Author: Donna Niedzwiecki, PhD – Duke Cancer Institute
    Author: Ryan Kramer, B.A. – Duke Univeristy School of Medicine
    Author: Cathlyn Medina, n/a – Duke University School of Medicine
    Author: Kristen E. Rhodin, MD, MHS – Duke University Medical Center
    Author: John Creasy, MD – The Oregon Clinic
    Author: Jeremy M. Sharib, MD (he/him/his) – Fred Hutchinson Cancer Center, University of Washington Medical Center
    Author: Benjamin Wildman-Tobriner, MD – Duke University School of Medicine
    Author: James Abbruzzese, MD – Duke University School of Medicine
    Author: Deanna Griffie, MSN, AGNP-BC – Duke Cancer Institute
    Author: John H. Strickler, MD – Duke University School of Medicine
    Author: David Hsu, MD PhD – Duke University School of Medicine
    Author: Daniel P. Nussbaum, MD – Duke University Medical Center
    Author: Sabino Zani, Jr., MD – Duke University Medical Center
    Author: Hope E. Uronis, MD – Duke University School of Medicine
    Author: Peter J. Allen, MD – Duke University Medical Center
    Author: Michael E. Lidsky, MD – Duke University Medical Center
    HPB
  • Saturday, Feb 17th
    8:10 AM - 8:20 AM AST
    29: The Association of Pre-Hepatic Artery Infusion Pump Systemic Chemotherapy with Intrahepatic Floxuridine Tolerance
    Location: Miramar I & II
    Abstract Presenter: Omar A. Zaki, MD – University of Kentucky College of Medicine Department of Surgery
    Submitter: Omar A. Zaki, MD – University of Kentucky College of Medicine Department of Surgery
    Author: Omar A. Zaki, MD – University of Kentucky College of Medicine Department of Surgery
    Author: Scott S. Ellis, PharmD – University of Kentucky College of Pharmacy
    Author: Daniel Davenport, PhD – University of Kentucky College of Medicine Department of Surgery
    Author: Mautin Barry-Hundeyin, MD – Division of Surgical Oncology, Department of Surgery, University of Kentucky
    Author: Prakash K. Pandalai, MD (he/him/his) – Division of Surgical Oncology, Department of Surgery, University of Kentucky
    Author: Joseph Kim, MD – Division of Surgical Oncology, Department of Surgery, University of Kentucky
    Author: Reema A. Patel, MD – Department of Internal Medicine, University of Kentucky
    Author: Michael J. Cavnar, MD – Division of Surgical Oncology, Department of Surgery, University of Kentucky
    HPB
  • Saturday, Feb 17th
    8:30 AM - 9:30 AM AST
    Management of Synchronous Rectal Cancer Liver Metastases
    Location: Miramar I & II
    Moderator: Lee M. Ocuin, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Moderator: Laleh Melstrom, MD – Division of Surgical Oncology, Department of Surgery, City of Hope National Medical Center, Duarte, CA
    HPBCME
  • Saturday, Feb 17th
    10:50 AM - 10:55 AM AST
    P14: Treatment Outcomes of Incidental Gallbladder Cancer – results from a high-volume tertiary care centre in North India
    Location: Miramar I & II
    Oral Poster Presenter: PUNEET PRAKASH, M.Ch. (SURGICAL ONCOLOGY) (he/him/his) – KING GEORGE'S MEDICAL UNIVERSITY
    Submitter: PUNEET PRAKASH, M.Ch. (SURGICAL ONCOLOGY) (he/him/his) – KING GEORGE'S MEDICAL UNIVERSITY
    Author: PUNEET PRAKASH, M.Ch. (SURGICAL ONCOLOGY) (he/him/his) – KING GEORGE'S MEDICAL UNIVERSITY
    Author: SAMEER GUPTA, M.Ch. (SURGICAL ONCOLOGY) – KING GEORGE'S MEDICAL UNIVERSITY
    Author: VIJAY KUMAR, M.Ch. (SURGICAL ONCOLOGY) – KING GEORGE'S MEDICAL UNIVERSITY
    Author: NASEEM AKHTAR, M.Ch. (SURGICAL ONCOLOGY) – KING GEORGE'S MEDICAL UNIVSERSITY
    Author: SHIV RAJAN, M.Ch (Surgical Oncology) – KING GEORGE'S MEDICAL UNIVERSITY
    Author: ARUN CHATURVEDI, M.S, MAMS – KING GEORGE'S MEDICAL UNIVSERSITY
    Author: Sanjeev Misra, M.Ch. (SURGICAL ONCOLOGY) – ATAL BIHARI VAJPAYEE MEDICAL UNIVERSITY
    HPB
  • Saturday, Feb 17th
    10:55 AM - 11:00 AM AST
    P16: Prospective Evaluation of the Safety and Quality of Life in Patients Receiving Hepatic Artery Infusion Pump Chemotherapy
    Location: Miramar I & II
    Oral Poster Presenter: LaDonna E. Kearse, MD (she/her/hers) – Mayo Clinic
    Submitter: LaDonna E. Kearse, MD (she/her/hers) – Mayo Clinic
    Author: Courtney Day, MS – Mayo Clinic
    Author: Travis E. Grotz, MD – Mayo Clinic, Rochester, MN, United States
    Author: Andrea Zironda, MD – Mayo Clinic
    Author: Jessica Mitchell, APRN, C.N.P., MS – Mayo Clinic
    Author: Zhaohui Jin, MD – Mayo Clinic
    Author: Susanne G. Warner, MD – Mayo Clinic
    Author: Cornelius A. Thiels, DO, MBA – Mayo Clinic
    HPB
  • Saturday, Feb 17th
    11:00 AM - 11:05 AM AST
    P15: Outcomes of hepatic artery-based therapies and systemic multiagent chemotherapy in unresectable colorectal liver metastases: A systematic review and meta-analysis
    Location: Miramar I & II
    Oral Poster Presenter: Kavin Sugumar, MD (he/him/his) – Department of Surgery, Tulane University School of Medicine
    Submitter: Kavin Sugumar, MD (he/him/his) – Department of Surgery, Tulane University School of Medicine
    Author: Kavin Sugumar, MD (he/him/his) – Department of Surgery, Tulane University School of Medicine
    Author: Henry Stizel, BS – 2. Case Western Reserve University School of Medicine, Cleveland, OH
    Author: Victoria Wu, BA – 2. Case Western Reserve University School of Medicine, Cleveland, OH
    Author: David Bajor, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Sakti Chakrabarti, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Madison Conces, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Lauren Henke, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Melissa Lumish, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Amit Mahipal, MD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Amr Mohamed, MD – Department of Medicine, Division of Hematology/Oncology, University Hospitals Seidman Cancer Center, case Western Reserve University, Cleveland, OH
    Author: Jordan M. Winter, MD, MBA – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Jeffrey M. Hardacre, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: John B. Ammori, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Jennifer Selfridge, MD, PhD – 3. Department of Medicine, Division of Hematology/Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    Author: Lee M. Ocuin, MD – 4. Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, Cleveland, OH
    HPB
  • Saturday, Feb 17th
    11:05 AM - 11:10 AM AST
    P13: Pre-operative biomarkers may predict nodal status in pancreas adenocarcinoma
    Location: Miramar I & II
    Oral Poster Presenter: Noah STEPHEN Brown, MD – University of Utah Hospital
    Submitter: Noah STEPHEN Brown, MD – University of Utah Hospital
    Author: Noah STEPHEN Brown, MD – University of Utah Hospital
    Author: Matthew Firpo, PhD – University of Utah, Department of Surgery
    Author: Courtney L. Scaife, MD – Huntsman Cancer Institute
    HPB
  • Saturday, Feb 17th
    1:35 PM - 3:05 PM AST
    HPB Workshop: Liver Augmentation Strategies
    Location: Miramar I & II
    Moderator: Susanne G. Warner, MD – Mayo Clinic
    Moderator: Michael E. Lidsky, MD – Duke University Medical Center
    HPBnon-CME
  • Sunday, Feb 18th
    8:30 AM - 8:35 AM AST
    P21: Decreased Primary Tumor Th2 Cell Tumor Infiltration is Associated with Liver Metastases Across Cancer Types
    Location: Miramar I & II
    Author: Madeline Silva, MD – UTHSCSA
    Author: Shirley Nah, MD – UTHSCSA
    Author: Ankur Tiwari, MBBS – University of Texas Health Science Center San Antonio
    Author: Caitlin A. McIntyre, MD – University of Texas Health Science Center San Antonio
    Author: Mio Kitano, MD (she/her/hers) – UT Health San Antonio - Mays Cancer Center
    Author: Alexander A. Parikh, MD, MPH, FACS, FSSO – UT Health San Antonio MD Anderson Mays Cancer Center
    Oral Poster Presenter: Colin M. Court, MD, PhD (he/him/his) – University of Texas Health Science Center at San Antonio
    Submitter: Colin M. Court, MD, PhD (he/him/his) – University of Texas Health Science Center at San Antonio
    Author: Colin M. Court, MD, PhD (he/him/his) – University of Texas Health Science Center at San Antonio
    HPBApplied Research